Consistently, Zhao and colleagues have demonstrated that SAB reverses atherosclerosis and inflammation by suppressing nuclear translocation of NF-κB and NLRP3 inflammasome activation in TNF-α-treated human umbilical vein endothelial cells [32]. This evidence concerns the gene NFKB1 and atherosclerosis.